Table 1 Summary of the cost-effectiveness literature of CMR for CAD (15 total studies)

Setting

 US setting

Moschetti et al. [24], Stojanovic et al. [29], Sharples et al. [28], Genders et al. [20], Ge et al. [13, 31]

 European setting (including the UK)

Walker et al. [14], Boldt et al. [22], Thom et al. [30], Petrov et al. [25], Pontone et al. [27], Pletscher et al. [26], Moschetti et al. [24], Sharples et al. [28], Genders et al. [20], Campbell et al. [23], Walker et al. [31]

 Other setting

Bertoldi et al. [21], Kozor et al. [32]

Comparators included

 No imaging

Genders et al. [20], Ge et al. [13]

 Stress echocardiography

Thom et al. [30], Sharples et al. [28], Genders et al. [20], Bertoldi et al. [21]

 Stress electrocardiography

Walker et al. [14], Pletscher et al. [26], Bertoldi et al. [21], Walker et al. [31]

 SPECT

Walker et al. [14], Boldt et al. [22], Thom et al. [30], Pletscher et al. [26], Sharples et al. [28], Genders et al. [20], Stojanovic et al. [29], Sharples et al. [28], Ge et al. [13], Walker et al. [31], Kozor et al. [32], Walker et al. [31]

 CCTA

Pontone et al. [27], Genders et al. [20], Bertoldi et al. [21], Ge et al. [13]

 Immediate coronary angiography

Walker et al. [14], Boldt et al. [22], Thom et al. [30], Petrov et al. [25], Pletscher et al. [26], Moschetti et al. [24], Sharples et al. [28], Ge et al. [13], Walker et al. [31], Kozor et al. [32]

Main conclusion on CMR value

 CMR cost-effective

Walker et al. [14], Boldt et al. [22], Petrov et al. [25], Pontone et al. [27], Pletscher et al. [26], Moschetti et al. [24], Stojanovic et al. [29], Ge et al. [13], Walker et al. [31], Kozor et al. [32]

 CMR not cost-effective

Genders et al. [20], Bertoldi et al. [21]

 Unclear cost-effectiveness

Thom et al. [30], Sharples et al. [28], Campbell et al. [23]

Key drivers of cost-effectiveness results

 Underlying CAD prevalence

Walker et al. [14], Boldt et al. [22], Thom et al. [30], Pletscher et al. [26], Moschetti et al. [24], Stojanovic et al. [29], Genders et al. [20], Ge et al. [13], Kozor et al. [32]

 Test costs

Pletscher et al. [26], Moschetti et al. [24], Sharples et al. [28], Bertoldi et al. [21]

Perspective taken

 Societal

Genders et al. [20]

 Healthcare system or payer

Walker et al. [14], Boldt et al. [22], Pletscher et al. [26], Moschetti et al. [24], Stojanovic et al. [29], Bertoldi et al. [21], Campbell et al. [23], Ge et al. [13], Walker et al. [31], Kozor et al. [32]

 Hospital

Stojanovic et al. [29]

 Not clearly stated

Thom et al. [30], Petrov et al. [25], Pontone et al. [27], Sharples et al. [28]

Model time horizon

 Lifetime

Walker et al. [14], Pletscher et al. [26], Genders et al. [20], Bertoldi et al. [21], Campbell et al. [23], Ge et al. [13], Kozor et al. [32]

 10–30 years

Boldt et al. [22], Petrov et al. [25]

 3–10 years

Thom et al. [30]

 < 3 years

Pontone et al. [27], Stojanovic et al. [29], Sharples et al. [28], Walker et al. [31]

 Not stated

Moschetti et al. [24]